Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first authorized generic versions of Mallinckrodt's Amitiza® (lubiprostone) 8 mcg and 24 mcg capsules. According to IQVIA™, Amitiza® capsule sales were approximately $427 million for the 12 months ended September 30,...
Timestamp (black vertical line) : Mar 1 2020 ---> Lockdowns worldwide due to Covid-19 - - - - - - - - - - - - - - - - - - - - - - - - - - - GlaxoSmithKline plc ( GSK ) LSE:GSK GlaxoSmithKline plc ( GSK ) is a British multinational pharmaceutical company headquartered in Brentford, England. Price decrease of 9.50% - - - - - - - - - - - - - - - - - - - - - - -...
Timestamp (black vertical line) : Mar 1 2020 ---> Lockdowns worldwide due to Covid-19 - - - - - - - - - - - - - - - - - - - - - - - - - - - GlaxoSmithKline plc (GSK) LSE:GSK GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, England. Price decrease of 9.50% - - - - - - - - - - - - - - - - - - - - -...
Not much history on this stock but with more potential lockdowns telemedicine seems like a buy to me. Testing my luck on this one. We have to at least bounce off support If it reaches $49-50 then we would have a cup and handle and target of $60-65 is possible. However, nothing on this chart screams BUY to me. Sometimes you have to make dumb decisions to get dumb...
BUY CALL FOR BSE:ANUHPHR for short term target - 218 expected profit - 50%
Cipla is showing negative divergences on a 15 minutes time frame. Ideally, when price makes a new high and RSI fails to make a new high, it gives a good signal for a short term pullback. However, pharma is in a strong bull rally, so entry and exit should be real quick. Target 1 - 810 target 2 - 795
Sun pharma is the biggest contributor in the Indian Pharma Index. So far, it has acted like a tired lion however, it seems the lion is ready to claim the kingship all over again. Sun pharma has broken its 3-year downward trendline. RSI has already passed its complexion point. It completed its corrective wave (2) at 450 levels around September. It is all set to...
NSE:SUNPHARMA Disclaimer: I am not SEBI registered person please contact your financial advisor before any investment decision.
ENTER WHERE THE MASSES HAVE THEIR STOP LOSS TRAIL TO COST WHEN REWARD IS 70% OF THE RISK TAKEN. RISK REWARD - 2:2 ALTHOUGH MARKET UNCERTAINTY IF FAR BEYOND MY ANALYSIS. GOOD LUCK TRADE AT YOUR OWN RISK!
inverted head and shoulders spotted in sun pharma pharma sector is showing positive signs nowadays so this is a good buying opportunity go long above ~518-219 target is easy 1% that is around 526 swing traders can take risk and go for a much bigger target intraday people enter wisely
Pre market price at 98.9 is above 95 resistance after covid-19 vaccine test results. Also all time high, which makes it bullish
In H4, the stock is forming price action in ascending triangle pattern. Currently is consolidating between 5.42 and 5.80. A good entry would be after it breakout from the triangle @ EP 5.86 with Support at 5.38. TP is at 6.73 and new 52WH 8.25 (Fibo 1.272) - RRR 1:1.8 EP 5.86 TP 6.73 / 8.25 SL 5.38 Stochastic shows a pullback signal, MACD didn’t signal any...
Stock has has been correcting for a while. Nifty Pharma has also been correcting and could show rebound anytime soon. Stock has taken strong support at 4800-4850 levels and has given a rebound as well. Good time to start accumulating the stock. MACD is has also given sign for reversal. 1st Target: 5330 2nd Target: 5500 SL@4700
Monthly Uptrend Weekly Uptrend Daily range with no clear TP and orientirs Trade possibe but with tight SL and speculative. Wait for formation
{TORNTPHARM} HAS A BEAUTIFUL VIEW ON BOTH SIDE ... WE HAVE TO PREPARE ON BOTH SIDE THANKYOU :) MORE CHANCE OF BREAKOUT **** IF BREAK WE CAN LONG .......: FOLLOW FOR MORE UPDATE THANKYOU :)